Back to School: How biopharma can reboot drug development. Access exclusive analysis here

MorphoSys, Celgene partner for MOR202

MorphoSys AG (Xetra:MOR; Pink:MPSYF) partnered with Celgene Corp. (NASDAQ:CELG) to co-develop worldwide and co-commercialize

Read the full 140 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE